Billing and Claims

CMS released the 2020 OPPS proposed rule July 29, proposing to refine previous policies related to price transparency and the 2-midnight rule, moving forward with year two of the site-neutral payment policy for clinic visits, while also asking for comments on how to potentially undo its policy that reduced payments for drugs purchased under the 340B drug discount program by nearly 30%.

The January 1, 2020, deadline for reporting Appropriate Use Criteria (AUC) for advanced diagnostic imaging is fast approaching—but organizations can’t wait until the new year to prepare.

A U.S. Senate bill aimed at protecting patients from surprise medical bills could also save the federal government about $7.5 billion over the next decade, according the Congressional Budget Office (CBO).

Q: What are the pros and cons of conducting a 100% retrospective charge segregation review for clinical trial claims?

Learn how to make the connections that will lead you to revenue integrity success with this issue of the quarterly NAHRI Journal.

Denise Williams, COC, CHRI, shares insight and analysis on Appropriate Use Criteria.

Learn what you need to do now to ensure seamless Appropriate Use Criteria reporting.

Take a look at how the Appropriate Use Criteria Program applies to different types of facilities and in different settings.

Use these expert answers to improve your organization’s lab DOS policy compliance.